It should follow the published method for the compound and the researchers institutional standard operating procedures
Lebrun C, Alchaar H, Candito M, et al
Mechanism of Action of GLP-1 / GIP (Zepbound) Medication
5mg per dose Primary Benefits Delivers sustained growth hormone-releasing hormone activity with extended half-life for prolonged pituitary stimulation and consistent GH levels
Obesity and overweight, which are common in patients with DM2, are a factors that favor the development/progression of CKD through both direct and indirect effects.69 Although the precise mechanisms the association between obesity and CKD are not totally defined it has been proposed that hypertension, glomerular hyperfiltration, hyperglycemia, lipid toxicity, inflammation or the role of adipose tissue and its adipokines are involved.70 Weight reduction by bariatric surgery, pharmacological treatment or dietary measures are associated with a nephroprotective effect,7173 so that weight reduction is a fundamental objective in the nephroprotection of patients with DKD
Dosing may be adjusted based on body weight and goals